Adenosine reduces the expression of T-cell adhesion molecules (e.g., ICAM-1, VCAM-1), limiting the homing of effector T cells to tumor tissue while inhibiting the antitumor activity of NK cells and macrophages (97, 105, 108). The gene discussed is ICAM1; the disease is neoplasm.